Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES

Approved

STANDARD

PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES

Takeda Products Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 28, 2020
Approval ID: 0b1d06f17dd6d44c
Company: Takeda Products Ireland Limited
Type: Standard

Approval Details

Approval Id: 0b1d06f17dd6d44c
Drug Cima Aemps Name: PANTECTA 40 mg COMPRIMIDOS GASTRORRESISTENTES
Register Number: PA2229-010-002
Holder Company Name: Takeda Products Ireland Limited
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2020-07-28
Dosage Form: COMPRIMIDO GASTRORRESISTENTE
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Takeda Products Ireland Limited

Active Ingredients

PANTOPRAZOL SODICO SESQUIHIDRATO

45,10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 28, 2020

Approval ID

0b1d06f17dd6d44c

Type

Standard

Back to CIMA-AEMPS Approvals